Humana Inc (HUM) - Total Assets
Based on the latest financial reports, Humana Inc (HUM) holds total assets worth $57.20 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Humana Inc - Total Assets Trend (1990–2025)
This chart illustrates how Humana Inc's total assets have evolved over time, based on quarterly financial data. Also see Humana Inc stock valuation for the company's overall valuation and market capitalisation.
Humana Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Humana Inc's total assets of $57.20 Billion consist of 15.3% current assets and 84.7% non-current assets. Review Humana Inc debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.20 Billion | 8.6% |
| Accounts Receivable | $3.27 Billion | 6.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $2.23 Billion | 4.6% |
| Intangible Assets | $1.13 Billion | 2.3% |
| Goodwill | $9.69 Billion | 19.9% |
Asset Composition Trend (1990–2025)
This chart illustrates how Humana Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Humana Inc (HUM) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Humana Inc's current assets represent 15.3% of total assets in 2025, a decrease from 19.8% in 1990.
- Cash Position: Cash and equivalents constituted 8.6% of total assets in 2025, up from 2.5% in 1990.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1990.
- Asset Diversification: The largest asset category is goodwill at 19.9% of total assets.
Humana Inc Competitors by Total Assets
Key competitors of Humana Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Oscar Health Inc
NYSE:OSCR
|
USA | $6.33 Billion |
|
Odontoprev S.A
SA:ODPV3
|
Brazil | R$2.25 Billion |
|
Qualicorp Consultoria e Corretora de Seguros S.A
SA:QUAL3
|
Brazil | R$3.43 Billion |
|
China Reform Health Management and Services Group Co Ltd
SHE:000503
|
China | CN¥1.75 Billion |
|
MEDI ASSIST HEALTHCARE SERVICES LIMITED
NSE:MEDIASSIST
|
India | Rs13.72 Billion |
|
UnitedHealth Group Incorporated
NYSE:UNH
|
USA | $309.73 Billion |
|
CVS Health Corp
NYSE:CVS
|
USA | $261.06 Billion |
|
Elevance Health Inc
NYSE:ELV
|
USA | $125.83 Billion |
Humana Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.74 | 0.75 | 0.63 |
| Quick Ratio | 1.74 | 0.75 | 0.63 |
| Cash Ratio | 0.00 | 0.36 | 0.44 |
| Working Capital | $17.08 Billion | $-2.79 Billion | $-3.65 Billion |
Humana Inc - Advanced Valuation Insights
This section examines the relationship between Humana Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.41 |
| Latest Market Cap to Assets Ratio | 0.90 |
| Asset Growth Rate (YoY) | 5.3% |
| Total Assets | $48.75 Billion |
| Market Capitalization | $44.10 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Humana Inc's assets close to their book value (0.90x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Humana Inc's assets grew by 5.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Humana Inc (1990–2025)
The table below shows the annual total assets of Humana Inc from 1990 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $48.75 Billion | +5.26% |
| 2024-12-31 | $46.31 Billion | -1.24% |
| 2023-12-31 | $46.89 Billion | +7.24% |
| 2022-12-31 | $43.73 Billion | -2.29% |
| 2021-12-31 | $44.75 Billion | +27.57% |
| 2020-12-31 | $35.08 Billion | +20.78% |
| 2019-12-31 | $29.04 Billion | +14.60% |
| 2018-12-31 | $25.34 Billion | -5.02% |
| 2017-12-31 | $26.68 Billion | +3.38% |
| 2016-12-31 | $25.81 Billion | +2.74% |
| 2015-12-31 | $25.12 Billion | +7.13% |
| 2014-12-31 | $23.45 Billion | +12.90% |
| 2013-12-31 | $20.77 Billion | +6.42% |
| 2012-12-31 | $19.52 Billion | +9.29% |
| 2011-12-31 | $17.86 Billion | +11.12% |
| 2010-12-31 | $16.07 Billion | +13.55% |
| 2009-12-31 | $14.15 Billion | +8.52% |
| 2008-12-31 | $13.04 Billion | +1.26% |
| 2007-12-31 | $12.88 Billion | +27.17% |
| 2006-12-31 | $10.13 Billion | +47.42% |
| 2005-12-31 | $6.87 Billion | +21.42% |
| 2004-12-31 | $5.66 Billion | +6.88% |
| 2003-12-31 | $5.29 Billion | +15.07% |
| 2002-12-31 | $4.60 Billion | +4.46% |
| 2001-12-31 | $4.40 Billion | +5.68% |
| 2000-12-31 | $4.17 Billion | -14.96% |
| 1999-12-31 | $4.90 Billion | -10.84% |
| 1998-12-31 | $5.50 Billion | +1.44% |
| 1997-12-31 | $5.42 Billion | +71.84% |
| 1996-12-31 | $3.15 Billion | +9.56% |
| 1995-12-31 | $2.88 Billion | +47.06% |
| 1994-12-31 | $1.96 Billion | +13.06% |
| 1993-12-31 | $1.73 Billion | -54.01% |
| 1992-12-31 | $3.76 Billion | -14.98% |
| 1991-12-31 | $4.43 Billion | +12.48% |
| 1990-12-31 | $3.94 Billion | -- |
About Humana Inc
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medic… Read more